Patisiran Benefits ATTR Amyloidosis With Cardiomyopathy: APOLLO-B Patisiran Benefits ATTR Amyloidosis With Cardiomyopathy: APOLLO-B

More details of the positive results with the RNAi therapeutic on functional capacity and quality of life were reported today.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news